Perfil de la empresa para Cyclo Therapeutics, Inc. - Warrant Acción
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Análisis de IA de Cyclo Therapeutics, Inc. - Warrant
Haz clic en cualquier análisis a continuación para obtener información instantánea de la IA de finAgent
Últimos análisis de IA sobre Cyclo Therapeutics, Inc. - Warrant
Aún no hay hilos de IA disponibles para esta empresa.